Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 19.91
(0.05%)
CNY 19.91
(0.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 463.02 Million CNY | 12.45% |
| 2022 | 439.48 Million CNY | 7.93% |
| 2021 | 407.19 Million CNY | 30.11% |
| 2020 | 312.96 Million CNY | 4.95% |
| 2019 | 298.19 Million CNY | 36.38% |
| 2018 | 218.64 Million CNY | 32.96% |
| 2017 | 164.45 Million CNY | 9.24% |
| 2016 | 150.53 Million CNY | 20.13% |
| 2015 | 125.31 Million CNY | 2.75% |
| 2014 | 121.96 Million CNY | 16.84% |
| 2013 | 104.38 Million CNY | 32.53% |
| 2012 | 78.76 Million CNY | 44.95% |
| 2011 | 54.33 Million CNY | 52.02% |
| 2010 | 35.74 Million CNY | 37.79% |
| 2009 | 25.94 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 119.24 Million CNY | -8.18% |
| 2024 Q3 | 154.81 Million CNY | 21.0% |
| 2024 Q1 | 129.86 Million CNY | -2.03% |
| 2023 Q4 | 132.55 Million CNY | -4.49% |
| 2023 FY | 494.18 Million CNY | 12.45% |
| 2023 Q1 | 106.97 Million CNY | -15.98% |
| 2023 Q2 | 115.86 Million CNY | 8.31% |
| 2023 Q3 | 138.78 Million CNY | 19.78% |
| 2022 FY | 439.48 Million CNY | 7.93% |
| 2022 Q4 | 127.32 Million CNY | -3.23% |
| 2022 Q1 | 91.82 Million CNY | -19.42% |
| 2022 Q2 | 88.76 Million CNY | -3.33% |
| 2022 Q3 | 131.57 Million CNY | 48.22% |
| 2021 Q3 | 115.15 Million CNY | 21.36% |
| 2021 FY | 407.19 Million CNY | 30.11% |
| 2021 Q1 | 83.2 Million CNY | 2.09% |
| 2021 Q2 | 94.88 Million CNY | 14.05% |
| 2021 Q4 | 113.94 Million CNY | -1.05% |
| 2020 Q1 | 65.46 Million CNY | -21.88% |
| 2020 FY | 312.96 Million CNY | 4.95% |
| 2020 Q4 | 81.49 Million CNY | -14.27% |
| 2020 Q3 | 95.06 Million CNY | 34.0% |
| 2020 Q2 | 70.94 Million CNY | 8.37% |
| 2019 FY | 298.19 Million CNY | 36.38% |
| 2019 Q4 | 83.79 Million CNY | -4.21% |
| 2019 Q3 | 87.48 Million CNY | 35.12% |
| 2019 Q2 | 64.74 Million CNY | 4.14% |
| 2019 Q1 | 62.17 Million CNY | -8.11% |
| 2018 Q1 | 42.44 Million CNY | -10.34% |
| 2018 Q4 | 67.65 Million CNY | 12.39% |
| 2018 FY | 218.64 Million CNY | 32.96% |
| 2018 Q3 | 60.2 Million CNY | 24.53% |
| 2018 Q2 | 48.34 Million CNY | 13.9% |
| 2017 Q1 | 35.2 Million CNY | -20.58% |
| 2017 Q2 | 38.09 Million CNY | 8.21% |
| 2017 Q3 | 43.82 Million CNY | 15.05% |
| 2017 Q4 | 47.33 Million CNY | 8.02% |
| 2017 FY | 164.45 Million CNY | 9.24% |
| 2016 FY | 150.53 Million CNY | 20.13% |
| 2016 Q1 | 33.81 Million CNY | -2.2% |
| 2016 Q2 | 33.35 Million CNY | -1.36% |
| 2016 Q3 | 39.04 Million CNY | 17.06% |
| 2016 Q4 | 44.32 Million CNY | 13.52% |
| 2015 FY | 125.31 Million CNY | 2.75% |
| 2015 Q4 | 34.57 Million CNY | 1.41% |
| 2015 Q3 | 34.09 Million CNY | 23.65% |
| 2015 Q2 | 27.57 Million CNY | -5.14% |
| 2015 Q1 | 29.06 Million CNY | -5.41% |
| 2014 Q1 | 34.59 Million CNY | 15.26% |
| 2014 Q4 | 30.73 Million CNY | 0.12% |
| 2014 Q3 | 30.69 Million CNY | 18.32% |
| 2014 Q2 | 25.94 Million CNY | -25.01% |
| 2014 FY | 121.96 Million CNY | 16.84% |
| 2013 Q1 | 23.16 Million CNY | 231.45% |
| 2013 FY | 104.38 Million CNY | 32.53% |
| 2013 Q4 | 30.01 Million CNY | 15.12% |
| 2013 Q3 | 26.07 Million CNY | 3.71% |
| 2013 Q2 | 25.13 Million CNY | 8.52% |
| 2012 FY | 78.76 Million CNY | 44.95% |
| 2012 Q4 | -17.62 Million CNY | 39.41% |
| 2012 Q3 | -29.08 Million CNY | 0.0% |
| 2011 FY | 54.33 Million CNY | 52.02% |
| 2010 FY | 35.74 Million CNY | 37.79% |
| 2009 FY | 25.94 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.36 Billion CNY | 66.053% |
| Zhejiang Zhenyuan Share Co., Ltd. | 654.18 Million CNY | 29.221% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 548.76 Million CNY | 15.624% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 343.25 Million CNY | -34.894% |
| Yifan Pharmaceutical Co., Ltd. | 2.82 Billion CNY | 83.632% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 307.2 Million CNY | -50.723% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.5 Billion CNY | 93.834% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 564.68 Million CNY | 18.003% |
| Boai NKY Medical Holdings Ltd. | 309.15 Million CNY | -49.774% |